Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Neutrophil elastase; Preterm birth; Secretory leukocyte protease inhibitor; Short cervix;
مقالات ISI مهار کننده پروتئاز لکوستیک ترشحی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Organ donation; Biomarker; Clinical trial; Transplantation; Risk prediction; Brain death; IL-6; interleukin-6; SLPI; secretory leukocyte protease inhibitor; IDI; integrated discrimination improvement; DND; donation after neurologic death; MOnIToR; Monitor
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Anticoagulants; Cytokine; Luminex; Validation; Serum; Plasma; IL; interleukin; CC; CC-chemokine (beta chemokine); CXC; CXC-chemokine (alpha chemokine); XC; C-chemokine (gamma chemokine); TNF; tumor necrosis factor; IFN; interferon; LIGHT; homologous to ly
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Elafin; Secretory leukocyte protease inhibitor; Rheumatoid arthritis; Systemic sclerosis;
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; antiprotease; biomarker; delivery; inflammation; prediction; secretory leukocyte protease inhibitor; term pregnancy;
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; SLPI; secretory leukocyte protease inhibitor; CF; cystic fibrosis; Smartphone; mHealth; Point-of-care; Electrochemical biosensor; Audio jack; Power rectification;
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Lard; Secretory leukocyte protease inhibitor; Acute lung injury; High-fat diet; Lipopolysaccharide; Sepsis;
Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; antimicrobials; cervical vaginal lavage; β-defensin 2; female reproductive tract; HIV; menstrual cycle; MIP-3α; mucosal factors; postmenopausal; secretory leukocyte protease inhibitor; tumor necrosis factor-α;
Predictive biomarkers of preterm delivery in women with ongoing IVF pregnancies
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; IVF; in vitro fertilization; PTD; preterm delivery; HE4; human epididymal protein 4; SLPI; secretory leukocyte protease inhibitor; IGF-I; insulin-like growth factor; IGF-II; insulin growth factor II; IGFBP-1; insulin growth factor binding protein-1; IVF-E
The role of toll-like and protease-activated receptors in the expression of cytokines by gingival fibroblasts stimulated with the periodontal pathogen Porphyromonas gingivalis
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Fibroblasts; Porphyromonas gingivalis; CXCL8; Interleukin-6; Secretory leukocyte protease inhibitor
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Chronic obstructive pulmonary disease; dendritic cells; regulatory T cells; IL-27; IL-10; inducible costimulator ligand; AHR; Aryl hydrocarbon receptor; APC; Antigen-presenting cell; BAL; Bronchoalveolar lavage; CD1c+DCCOPD; CD1c+ DCs from lung samples ob
Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; SLPI; secretory leukocyte protease inhibitor; HPV; human papillomavirus; HNC; head and neck cancer; OD; optical density; CV; coefficients of variation.; Secretory leukocyte protease inhibitor; SLPI; Innate immunity; Immune system protein; Oral disease; Or
NMR and molecular modelling studies on elastase inhibitor-peptides for wound management
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; MMPs; matrix metalloproteinases; PPE; porcine pancreatic elastase; SLPI; secretory leukocyte protease inhibitor; Pep4; KRCCPDTCGIKCL; Pep4(P); Pep4 phosphorylated; Pep4M; KRMMPDTMGIKML; Pep4M(P); Pep4M phosphorylated; PepBBI (Bowman-Birk inhibitor); WCTAS
Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Nrf2; NF-E2-related factor 2; BM; bone marrow; BMT; bone marrow transplantation; LDL; low density lipoprotein; CM; chylomicron; HDL; high-density lipoprotein; TG; triglyceride; CHO; cholesterol; VCAM-1; vascular cell adhesion molecule 1; ICAM-1; intercell
Endocrine control of mucosal immunity in the female reproductive tract: Impact of environmental disruptors
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; FRT; female reproductive tract; GM-CSF; granulocyte macrophage colony stimulating factor; SLPI; secretory leukocyte protease inhibitor; HBD2; human β defensin 2; MIP; macrophage inflammatory protein; MCP-1; Monocyte chemotactic protein-1; IL; interleukin
The alarm secretory leukocyte protease inhibitor increases with progressive metabolic dysfunction
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Secretory leukocyte protease inhibitor; Metabolic syndrome; Diabetes; Uric acid; Lipid; sTNFR2;
Micro-encapsulated secretory leukocyte protease inhibitor decreases cell-mediated immune response in autoimmune orchitis
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Autoimmune orchitis; Secretory leukocyte protease inhibitor; Drug delivery systems; Immuno-modulation; Delayed type hypersensitivity;
An improved method for enhanced production and biological activity of human secretory leukocyte protease inhibitor (SLPI) in Pichia pastoris
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Pichia pastoris; Recombinant expression; Protein disulfide isomerase; Secretory leukocyte protease inhibitor; Selectable markersPDI, protein disulfide isomerase; SLPI, secretory leukocyte protease inhibitor
Lung protease/anti-protease network and modulation of mucus production and surfactant activity
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Neutrophil elastase; Elafin; SLPI; Surfactant proteins; Mucus; AE; alveolar epithelial cells type I (I) or type (II); AM; alveolar macrophage; AR; amphiregulin; BALF; bronchoalveolar lavage fluid; CF; cystic fibrosis; COPD; chronic obstructive pulmonary d
Temporal Induction of Secretory Leukocyte Protease Inhibitor (SLPI) in Odontoblasts by Lipopolysaccharide and Wound Infection
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Inflammatory response; lipopolysaccharide; odontoblast; secretory leukocyte protease inhibitor; wound
Alteration of secretory leukocyte protease inhibitor in human myometrium during labor
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; inflammation; myometrium; nuclear factor-κB; parturition; secretory leukocyte protease inhibitor;
Antibodies to the 70 kDa heat shock protein in midtrimester amniotic fluid and intraamniotic immunity
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; amniotic fluid; heat shock protein; heat shock protein antibodies; immune regulation; interferon-α; secretory leukocyte protease inhibitor; tumor necrosis factor-α;
A Pilot Study of Fecal Serine-Protease Activity: A Pathophysiologic Factor in Diarrhea-Predominant Irritable Bowel Syndrome
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; IBS; irritable bowel syndrome; IBS-A; irritable bowel syndrome with alternating habits; IBS-C; constipation-predominant irritable bowel syndrome; IBS-D; diarrhea-predominant irritable bowel syndrome; PAR; proteinase-activated receptor; SLPI; secretory leu
Protease inhibitors and their peptidomimetic derivatives as potential drugs
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; α1-PI; alpha1-protease inhibitor; 3D-QSAR; three-dimensional quantitative structure-activity relationship; ACE; angiotensin-converting enzyme; AIDS; acquired immune deficiency syndrome; BBI; Bowman-Birk inhibitor; BBIC; Bowman-Birk inhibitor concentrat
Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Oesophageal cancer surgery; Secretory leukocyte protease inhibitor; Steroid therapy
Development of affinity chromatography using a bioactive peptide as a ligand
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Nonspecific binding proteins; Affinity chromatography; Hydrophilic spacer; Secretory leukocyte protease inhibitor
Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; secretory leukocyte protease inhibitor; aqueous humours; eye; protease inhibitors
Relationship between secretory leukocyte protease inhibitor levels in bronchoalveolar lavage fluid and postoperative pulmonary complications in patients with esophageal cancer
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; Bronchoalveolar lavage fluid; Esophagectomy; Pulmonary complication; Secretory leukocyte protease inhibitor;
Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function
Keywords: مهار کننده پروتئاز لکوستیک ترشحی; IkB; inhibitor for NF-κB; IKK; IkB kinase; IRAK; IL-1 receptor associated kinase; MyD88; myeloid differentiation antigen 88; SLPI; secretory leukocyte protease inhibitor; TIR; toll IL-1 receptor; TIRAP; TIR domain-containing adapter protein; TRAF; TNF re